🇺🇸 FDA
Pipeline program

Two doses of quadrivalent influenza vaccine

PRO-QINF-4002

Approved mab completed

Quick answer

Two doses of quadrivalent influenza vaccine for Seasonal Influenza is a Approved program (mab) at SINOVAC BIOTECH LTD with 1 ClinicalTrials.gov record(s).

Program details

Company
SINOVAC BIOTECH LTD
Indication
Seasonal Influenza
Phase
Approved
Modality
mab
Status
completed

Clinical trials